Pulkes T, Hanna M G
Muscle and Neurogenetics Sections, University Department of Clinical Neurology, Institute of Neurology, University College London, Queen Square, WC1N 3BG, London, UK.
Adv Drug Deliv Rev. 2001 Jul 2;49(1-2):27-43. doi: 10.1016/s0169-409x(01)00124-7.
The mitochondrial encephalomyopathies are a genetically heterogeneous group of disorders associated with impaired oxidative phosphorylation. Patients may exhibit a wide range of clinical symptoms and experience significant morbidity and mortality. There is currently no curative treatment. At present the majority of genetically defined mitochondrial encephalomyopathies are caused by mutations in mitochondrial DNA. The underlying molecular mechanisms and the complex relationship between genotype and phenotype in these mitochondrial DNA diseases remain only partially understood. We describe the key features of mitochondrial DNA genetics and outline some of the common disease phenotypes associated with mtDNA defects. A classification of pathogenic mitochondrial DNA point mutations which may have therapeutic implications is outlined.
线粒体脑肌病是一组遗传异质性疾病,与氧化磷酸化受损有关。患者可能表现出广泛的临床症状,并经历显著的发病率和死亡率。目前尚无治愈性治疗方法。目前,大多数基因明确的线粒体脑肌病是由线粒体DNA突变引起的。这些线粒体DNA疾病的潜在分子机制以及基因型与表型之间的复杂关系仍仅部分为人所知。我们描述了线粒体DNA遗传学的关键特征,并概述了一些与线粒体DNA缺陷相关的常见疾病表型。概述了可能具有治疗意义的致病性线粒体DNA点突变分类。